BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10077446)

  • 1. Pharmacokinetic evaluation of biodistribution data obtained with radiolabeled proteins in mice.
    Nishikawa M; Staud F; Takemura S; Takakura Y; Hashida M
    Biol Pharm Bull; 1999 Feb; 22(2):214-8. PubMed ID: 10077446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver.
    Arano Y; Mukai T; Akizawa H; Uezono T; Motonari H; Wakisaka K; Kairiyama C; Yokoyama A
    Nucl Med Biol; 1995 Jul; 22(5):555-64. PubMed ID: 7581163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
    Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
    Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
    Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
    J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
    Nishikawa M; Miyazaki C; Yamashita F; Takakura Y; Hashida M
    Am J Physiol; 1995 May; 268(5 Pt 1):G849-56. PubMed ID: 7762669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.
    Nishida K; Eguchi Y; Takino T; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1991 Oct; 8(10):1253-7. PubMed ID: 1796043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.
    Ogawara K; Nishikawa M; Takakura Y; Hashida M
    J Control Release; 1998 Jan; 50(1-3):309-17. PubMed ID: 9685898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
    Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH
    J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
    Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
    J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice.
    Masuda H; Takakura Y; Hashida M
    Biochim Biophys Acta; 1999 Feb; 1426(3):420-8. PubMed ID: 10076058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of in vivo fate of albumin derivatives utilizing combined chemical modification.
    Fujita T; Nishikawa M; Ohtsubo Y; Ohno J; Takakura Y; Sezaki H; Hashida M
    J Drug Target; 1994; 2(2):157-65. PubMed ID: 8069594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.
    Nishikawa M; Hirabayashi H; Takakura Y; Hashida M
    Pharm Res; 1995 Feb; 12(2):209-14. PubMed ID: 7784335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and Intrahepatic Targeting of Hydrogen Sulfide Prodrug by Bioconjugation.
    Sakai K; Katsumi H; Kamano K; Yamauchi K; Hajima A; Morishita M; Sakane T; Yamamoto A
    Biol Pharm Bull; 2019; 42(2):273-279. PubMed ID: 30713258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.